ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 28 filers reported holding ASLAN PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $32 | -99.7% | 88,106 | +389.6% | 0.00% | +300.0% |
| Q3 2022 | $11,000 | +22.2% | 17,997 | -0.7% | 0.00% | 0.0% |
| Q2 2022 | $9,000 | -60.9% | 18,119 | -30.6% | 0.00% | -50.0% |
| Q1 2022 | $23,000 | -75.5% | 26,101 | -50.4% | 0.00% | -75.0% |
| Q3 2021 | $94,000 | -54.8% | 52,590 | -15.2% | 0.01% | -46.7% |
| Q1 2021 | $208,000 | +700.0% | 61,997 | +346.2% | 0.02% | +400.0% |
| Q4 2020 | $26,000 | -76.4% | 13,895 | -74.5% | 0.00% | -72.7% |
| Q4 2019 | $110,000 | – | 54,386 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,270,758 | $2,262,000 | 0.72% |
| MANGROVE PARTNERS IM, LLC | 2,514,576 | $4,476,000 | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 975,305 | $1,736,000 | 0.36% |
| DAFNA Capital Management LLC | 732,500 | $1,304,000 | 0.35% |
| KNOTT DAVID M | 478,186 | $851,000 | 0.31% |
| Vivo Capital, LLC | 2,840,909 | $5,057,000 | 0.23% |
| SABBY MANAGEMENT, LLC | 688,400 | $1,225,000 | 0.17% |
| MYDA Advisors LLC | 236,165 | $420,000 | 0.12% |
| Affinity Asset Advisors, LLC | 250,000 | $445,000 | 0.11% |
| RTW INVESTMENTS, LP | 3,250,000 | $5,785,000 | 0.09% |